1. Home
  2. STWD vs CYTK Comparison

STWD vs CYTK Comparison

Compare STWD & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$17.44

Market Cap

7.4B

Sector

Real Estate

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.49

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
CYTK
Founded
2009
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.6B
IPO Year
2009
2004

Fundamental Metrics

Financial Performance
Metric
STWD
CYTK
Price
$17.44
$64.49
Analyst Decision
Buy
Strong Buy
Analyst Count
4
18
Target Price
$20.13
$88.50
AVG Volume (30 Days)
3.0M
1.7M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
11.00%
N/A
EPS Growth
4.55
N/A
EPS
1.15
N/A
Revenue
$1,844,289,000.00
$13,368,000.00
Revenue This Year
$283.44
$8.73
Revenue Next Year
$17.66
$309.93
P/E Ratio
$15.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.59
$29.31
52 Week High
$20.99
$70.98

Technical Indicators

Market Signals
Indicator
STWD
CYTK
Relative Strength Index (RSI) 42.18 53.69
Support Level N/A $59.13
Resistance Level $18.56 $65.72
Average True Range (ATR) 0.30 2.66
MACD -0.02 0.19
Stochastic Oscillator 41.05 84.88

Price Performance

Historical Comparison
STWD
CYTK

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: